Cipla's Q1 PAT grows 24% to Rs 715 crore riding on domestic sales

The company posted a 27% YoY increase in income from operations, at Rs 5,504 cr. Ebitda grew 28% to Rs 1,346 cr with a resulting Ebitda margin of 24.5%

Mumbai-headquartered Cipla posted a 24 per cent growth in profit after tax (PAT) to Rs 715 crore for the June quarter riding on strong revenue growth in the India business as well as in the active pharmaceutical ingredients (API) business.

The company posted a 27 per cent YoY increase in income from operations, at Rs 5,504 crore during the quarter. The Ebitda grew by 28 per cent to Rs 1,346 crore with a resulting Ebitda margin of 24.5 per cent.

The India business grew 68 per cent to Rs 2,710 crore, led by chronic therapies and Covid-19 portfolio. The firm